España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Entrada Therapeutics
TRDA
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$17.12
-0.64
-3.60%
At Close: -
$17.12
0
0.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Get Report
Comment
Entrada Therapeutics (TRDA) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Entrada Therapeutics (NASDAQ:TRDA) Stock
Entrada Therapeutics Stock (NASDAQ: TRDA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
Zevra Rises on Update on Niemann-Pick Disease Type C Drug
Zacks
Tuesday, June 25, 2024
HC Wainwright & Co. Maintains Buy on Entrada ...
Benzinga Newsdesk
Monday, June 24, 2024
Entrada Therapeutics To Raise $100M Via Regis...
Benzinga Newsdesk
Entrada Therapeutics Announced Preliminary Da...
Benzinga Newsdesk
Tuesday, May 07, 2024
Entrada Therapeutics Expects Cash Runway Thro...
Benzinga Newsdesk
Entrada Therapeutics Q1 2024 GAAP EPS $0.68 M...
Benzinga Newsdesk
Thursday, April 11, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Insiders Buying America's Car-Mart And 2 Other Stocks
Avi Kapoor
Friday, March 22, 2024
Around $5M Bet On This Communication Services Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Monday, March 18, 2024
HC Wainwright & Co. Reiterates Buy on Entrada...
Benzinga Newsdesk
Wednesday, March 13, 2024
Recap: Entrada Therapeutics Q4 Earnings
Benzinga Insights
Entrada Therapeutics' Cash Balance Of $352M W...
Benzinga Newsdesk
Entrada Therapeutics Q4 GAAP EPS $(0.29) Miss...
Benzinga Newsdesk
Friday, January 05, 2024
Entrada Therapeutics shares are trading highe...
Benzinga Newsdesk
Oppenheimer Initiates Coverage On Entrada The...
Benzinga Newsdesk
Monday, November 27, 2023
HC Wainwright & Co. Maintains Buy Rating for Entrada Therapeutics: Here's What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Entrada ...
Benzinga Newsdesk
Thursday, November 23, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, November 22, 2023
Why Is Neuromuscular Disease Focused Entrada Therapeutics Shares Trading Lower Today?
Vandana Singh
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Entrada Therapeutics shares are trading lower...
Benzinga Newsdesk
Entrada Says FDA Clinical Hold On ENTR-601-44...
Benzinga Newsdesk
Entrada Plans To Announce Data From ENTR-601-...
Benzinga Newsdesk
Tuesday, November 07, 2023
Entrada Therapeutics' Cash Runway Expected Th...
Benzinga Newsdesk
Entrada Therapeutics Q3 EPS $1.02 May Not Be ...
Benzinga Newsdesk
Friday, September 22, 2023
HC Wainwright & Co. Reiterates Buy on Entrada...
Benzinga Newsdesk
Thursday, September 21, 2023
Entrada Therapeutics Announces First Particip...
Benzinga Newsdesk
Wednesday, August 09, 2023
HC Wainwright & Co. Reiterates Buy on Entrada...
Benzinga Newsdesk
Tuesday, August 08, 2023
Entrada Therapeutics shares are trading highe...
Benzinga Newsdesk
Entrada Therapeutics Q2 EPS $(0.78) Down From...
Benzinga Newsdesk
Wednesday, August 02, 2023
HC Wainwright & Co. Reiterates Buy on Entrada...
Benzinga Newsdesk
Monday, June 26, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Wednesday, May 24, 2023
HC Wainwright & Co. Reiterates Buy on Entrada...
Benzinga Newsdesk
Wednesday, May 10, 2023
Entrada Therapeutics Q1 EPS $(0.21) Up From $...
Benzinga Newsdesk
Monday, April 03, 2023
Benzinga's Top Ratings Upgrades, Downgrades For April 3, 2023
Benzinga Insights
HC Wainwright & Co. Initiates Coverage On Ent...
Benzinga Newsdesk
Thursday, March 09, 2023
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Monday, March 06, 2023
Entrada Therapeutics Cash, Cash Equivalents &...
Benzinga Newsdesk
Entrada Therapeutics Q4 EPS $(0.79) Beats $(0...
Benzinga Newsdesk
Thursday, February 16, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, February 15, 2023
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Tuesday, February 14, 2023
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, January 09, 2023
Entrada Therapeutics Announces Clinical Candi...
Bill Haddad
Tuesday, December 20, 2022
Dow Jumps 150 Points; Crude Oil Rises 1%
Lisa Levin
Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Nasdaq Edges Lower; Gold Rises 1.5%
Lisa Levin
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
Lisa Levin
Entrada Therapeutics shares are trading lower...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch